Baxter International, USA: Infusion, Renal Care, Critical Care and Medical Technology

by pritamkurrey111 · Published October 9, 2026 · Updated September 12, 2026

Introduction

Baxter International Inc. is a major American healthcare and medical technology company known for products used in hospitals, critical care units, operating rooms, infusion therapy, nutrition, pharmaceuticals and renal care.

For decades, Baxter has been associated with life-sustaining medical technologies, particularly intravenous therapy, infusion systems, dialysis and acute kidney-care technologies. Its products are used in hospitals, clinics, dialysis centres and other healthcare environments.

Baxter’s broader portfolio includes sterile IV solutions, infusion systems and administration sets, parenteral nutrition, injectable pharmaceuticals, surgical hemostats and sealants, advanced surgical equipment, smart hospital technologies, patient monitoring and respiratory-care products.

An Important Recent Change in Baxter’s Renal-Care Business

Baxter historically had one of the world’s largest renal-care businesses through its Kidney Care division. However, Baxter completed the sale of this business in 2025. The business became Vantive, meaning that many products historically associated with Baxter renal care are now part of a separate company.

Therefore, when discussing Baxter today, it is useful to distinguish between:

Baxter’s current medical-technology portfolio
Baxter’s historical Kidney Care business
Vantive’s current renal-care portfolio

Baxter’s 2025 annual report specifically describes the company after giving effect to the sale of its Kidney Care business.

What Does Baxter Make?

Baxter’s healthcare portfolio covers multiple medical specialties.

Major product categories include:

IV solutions
Infusion pumps
Infusion administration sets
Syringe pumps
Clinical nutrition products
Parenteral nutrition
Injectable pharmaceuticals
Surgical hemostats
Surgical sealants
Advanced surgical equipment
Patient monitoring technologies
Smart hospital beds
Respiratory-care devices
Critical-care technologies
Renal-care technologies historically associated with Baxter
Dialysis machines and dialysers through the former Kidney Care business
Peritoneal dialysis systems
Continuous renal replacement therapy systems
Hospital workflow technologies

Baxter’s current U.S. product catalogue includes infusion systems, IV solutions, clinical nutrition products and other hospital-care technologies.

1. Baxter Infusion Therapy

Infusion therapy is one of Baxter’s most important areas.

Infusion systems are used to deliver fluids, medicines, nutrients and other solutions into a patient’s body at controlled rates.

Baxter develops an ecosystem that can include:

Infusion pumps
Large-volume pumps
Syringe pumps
IV solutions
Administration sets
IV accessories
Drug-delivery technologies
Infusion software
Connectivity systems

These technologies are widely used in hospitals and other healthcare settings.

Baxter’s current infusion catalogue includes IV solutions, infusion systems and accessories, with multiple product categories available.

2. IQX Infusion Platform

One of Baxter’s newer infusion technologies is the IQX Infusion Platform.

The platform combines:

Spectrum IQ Large Volume Pump
Novum IQ Syringe Pump
IQ Enterprise Connectivity Suite

The purpose is to create a connected infusion-delivery ecosystem rather than treating each infusion pump as an isolated device.

Connected infusion technology can help healthcare organisations manage:

Infusion devices
Medication information
Device connectivity
Clinical workflows
Data
Pump management

3. Spectrum IQ Large-Volume Pump

The Spectrum IQ Large Volume Pump is designed for controlled delivery of fluids and medications.

Large-volume infusion pumps are commonly used for therapies requiring continuous or accurately controlled administration.

Potential applications include:

IV fluids
Medicines
Antibiotics
Nutrition
Critical-care therapies

Exact indications and configurations depend on the product version and regulatory approval in a particular country.

4. Novum IQ Syringe Pump

Baxter’s Novum IQ Syringe Pump is another component of its connected infusion portfolio.

Syringe pumps are useful when relatively small volumes need to be delivered with precise control.

They can be important in:

Intensive care
Neonatal care
Anaesthesia
Critical care
Medication delivery

The Novum IQ is integrated into Baxter’s IQX ecosystem.

5. IV Solutions

Baxter is also well known for intravenous solutions.

Its portfolio includes products such as:

Sodium chloride solutions
Sterile water
Dextrose solutions
Irrigation solutions
Other IV preparations

The company’s U.S. catalogue lists numerous IV solutions and related products.

IV solutions can be used for different clinical purposes, including fluid replacement and as carriers for certain medications.

The exact product availability and formulation differ by country.

6. Infusion Administration Sets

An infusion pump requires compatible administration components.

Baxter produces a variety of:

IV administration sets
Tubing
Connectors
Extension sets
IV accessories
Needleless access technologies

These products form part of the overall infusion system connecting the fluid container, pump and patient-access device.

7. Clinical Nutrition

Baxter also provides technologies for clinical nutrition.

Some patients cannot obtain adequate nutrition through normal eating and may require specialised nutritional support.

Baxter’s portfolio includes products for:

Parenteral nutrition
Enteral nutrition
Nutrient administration
Compounding
Nutrition delivery

Its product listing includes CLINIMIX nutritional formulations and EXACTAMIX Automated Compounding System, among other nutritional-care products.

8. Parenteral Nutrition

Parenteral nutrition delivers nutrients through an intravenous route when the gastrointestinal tract cannot provide sufficient nutrition.

Baxter has developed products used in parenteral nutrition, including:

Amino-acid formulations
Dextrose-containing formulations
Electrolyte-containing preparations
Compounding technologies
Nutrition administration systems

These products are generally used under professional medical supervision.

9. Critical Care

Critical care is another important Baxter business area.

Critical-care technologies are designed for patients who require intensive medical support.

Baxter’s critical-care portfolio has included technologies for:

Acute kidney injury
Continuous renal replacement therapy
Extracorporeal therapies
Fluid management
ICU support
Organ-support therapies

Baxter’s current critical-care activities include technologies such as the PRISMAFLEX System and associated hemofilter and replacement-solution products in markets where they remain available.

10. Continuous Renal Replacement Therapy

Continuous renal replacement therapy (CRRT) is used primarily for critically ill patients with acute kidney injury or other situations requiring gradual extracorporeal blood purification.

Unlike conventional intermittent haemodialysis, CRRT is generally delivered continuously or over extended periods in the intensive-care environment.

Baxter has historically been a major provider of CRRT technology.

Its Prismaflex and related systems have been used for extracorporeal therapies in critical care.

Baxter reports approximately 20,000 CRRT devices installed worldwide and support for critical-care teams in around 90 countries on its acute-therapy information platform.

11. PRISMAFLEX System

The PRISMAFLEX System is associated with continuous renal replacement and other extracorporeal therapies.

Depending on the configuration and market, such systems can support therapies involving:

Continuous renal replacement therapy
Hemofiltration
Hemodiafiltration
Therapeutic plasma exchange
Other extracorporeal treatment applications

The system is designed for use in critical-care environments.

12. Renal Care and Dialysis

Renal care has historically been one of Baxter’s defining medical-technology businesses.

The former Baxter Kidney Care portfolio included technologies for both:

Hemodialysis

and

Peritoneal dialysis

It also included acute renal-replacement technologies for critically ill patients.

However, because Baxter sold its Kidney Care business in 2025, these renal products should now be understood primarily in the context of Vantive, the successor business.

13. Hemodialysis

Hemodialysis uses an extracorporeal circuit to remove waste products and excess fluid from the blood when the kidneys cannot perform these functions adequately.

The former Baxter renal portfolio included:

Dialysis machines
Dialysers
Blood tubing
Dialysis concentrates
Filters
Dialysis solutions
Water-treatment technologies

The former portfolio included systems such as Phoenix X36, along with dialysers such as Revaclear and Polyflux.

14. Peritoneal Dialysis

Baxter was also historically one of the major global providers of peritoneal dialysis (PD).

Peritoneal dialysis uses the patient’s peritoneal membrane as part of the filtration process.

Products historically associated with Baxter included:

AMIA Automated PD System
HomeChoice systems
DIANEAL PD Solution
EXTRANEAL PD Solution
PD tubing and accessories
Remote patient-management technology

The AMIA system was designed to support automated peritoneal dialysis and remote monitoring through the SHARESOURCE platform.

15. Home Dialysis Technology

One of the important developments in renal care has been the expansion of home-based dialysis.

Baxter’s former renal portfolio included technologies designed to support home peritoneal dialysis.

Remote patient-management systems could allow healthcare professionals to review treatment information and support patients receiving therapy at home.

The renal-care business is now separate from Baxter following the Kidney Care transaction.

16. Dialysers

A dialyser acts as an artificial filtering membrane during haemodialysis.

The former Baxter renal portfolio included:

Revaclear dialysers
Polyflux dialysers
Exeltra dialysers
Theranova technology

These products were designed for different dialysis applications and treatment requirements.

17. Critical Care and Multi-Organ Support

Modern ICU patients may need more than one organ-support therapy.

Baxter’s acute-therapy strategy has included combining multiple extracorporeal therapies.

Its critical-care platform describes the potential integration of:

CRRT
Therapeutic plasma exchange
ECCO₂R
Sepsis-management approaches

The objective is to simplify complex ICU workflows while providing extracorporeal organ support.

18. Surgical Products

Baxter also develops products for the operating room.

Its surgical portfolio includes:

Surgical hemostats
Tissue sealants
Adhesion-prevention products
Advanced surgical equipment
Surgical accessories

Examples in Baxter’s product catalogue include:

FLOSEAL Hemostatic Matrix
TISSEEL Fibrin Sealant
COSEAL Surgical Sealant
PERI-STRIPS DRY
ACTIFUSE bone-graft substitute

19. Surgical Hemostasis

During surgery, controlling bleeding is a major clinical requirement.

Baxter provides hemostatic technologies designed to assist surgeons in controlling bleeding.

One example is FLOSEAL, a hemostatic matrix.

Such products are used in selected surgical situations where conventional methods alone may not be sufficient.

Use depends on the specific product’s indications and the clinical judgment of the surgical team.

20. Surgical Sealants

Baxter also has technologies designed to help seal tissues during surgical procedures.

One example is TISSEEL, a fibrin sealant.

Surgical sealants may be used in selected procedures where surgeons require additional support for controlling bleeding or sealing tissues.

21. Patient Monitoring and Connected Care

Baxter’s portfolio also extends into connected hospital technologies.

The company provides or has provided:

Patient monitoring systems
Diagnostic technologies
Smart bed systems
Connected-care solutions
Hospital workflow technologies

Baxter’s 2025 annual report identifies smart beds, patient monitoring and diagnostic technologies as part of its Healthcare Systems & Technologies portfolio.

22. Smart Hospital Beds

Following the acquisition of Hillrom, Baxter expanded its hospital-care technology portfolio.

Smart beds can combine conventional hospital-bed functions with technology designed to support:

Patient positioning
Mobility
Fall-risk management
Bed monitoring
Clinical workflows
Connected hospital environments

These technologies are particularly relevant to hospitals attempting to create more digitally connected patient rooms.

23. Respiratory Care

Baxter also has a respiratory-health portfolio.

This area can include technologies and equipment used in:

Respiratory support
Acute care
Hospital respiratory therapy
Home respiratory care

Baxter’s current corporate reporting identifies respiratory-health devices among its healthcare products.

24. Pharmaceuticals

Baxter is not only a medical-device manufacturer.

Its portfolio also includes pharmaceutical products such as:

Injectable pharmaceuticals
Generic injectable medicines
Inhaled anaesthetics
Drug-compounding services

These products can support hospital and surgical-care workflows.

25. Hospital Pharmacy and Drug Compounding

Medication preparation is an important part of hospital care.

Baxter has technologies and services designed to support:

IV medication preparation
Pharmacy workflow
Drug compounding
Medication safety
Automated preparation

Its portfolio includes technologies such as DoseEdge Pharmacy Workflow Manager and other hospital-care solutions in selected markets.

26. Major Baxter Product Categories

Medical Area Examples Infusion IQX, Spectrum IQ, Novum IQ IV Solutions Sodium chloride, sterile water, dextrose and other solutions Clinical Nutrition CLINIMIX and nutrition-compounding technologies Critical Care PRISMAFLEX and extracorporeal therapies Renal Care* Dialysis systems, dialysers, PD systems Surgery Hemostats, sealants and surgical products Hospital Care Pharmacy, IV and workflow technologies Patient Monitoring Connected monitoring technologies Smart Hospital Smart beds and connected-care systems Respiratory Respiratory-care devices Pharmaceuticals Injectable medicines and inhaled anaesthetics

*Many renal-care products listed here were part of Baxter’s former Kidney Care business, which was separated from Baxter in 2025.

27. Baxter’s Global Presence

Baxter products are used across hospitals and other healthcare environments internationally.

According to Baxter’s 2025 annual report, after the Kidney Care divestiture the company manufactured products in more than 20 countries and sold products in more than 100 countries.

Its products serve:

Hospitals
Intensive-care units
Operating rooms
Clinics
Nursing facilities
Rehabilitation centres
Ambulatory surgery centres
Doctors’ offices
Patients receiving appropriate care at home

28. Baxter in India

Baxter has an established presence in India.

Its Indian product portfolio includes products and technologies associated with:

Critical care
Hospital care
Renal care
Nutritional care
Surgical care

The Baxter India product listing includes products such as PRISMAFLEX, PRISMASOL, AMIA, DIANEAL, EXTRANEAL, PHOENIX X36, REVACLEAR, SIGMA Spectrum Infusion System and CLINIMIX.

Because Baxter’s global business structure has changed, healthcare providers in India should verify the current supplier and ownership of individual renal products before purchasing.

29. Baxter’s Role in Critical Healthcare

Baxter’s importance comes from the fact that many of its technologies are used in situations where reliable medical equipment is essential.

For example:

Infusion → controlled delivery of medicines and fluids

Critical care → support for seriously ill patients

Renal replacement → extracorporeal support when kidney function is severely impaired

Surgery → bleeding control and tissue sealing

Nutrition → delivery of essential nutrients when normal feeding is not adequate

Hospital technology → connected beds, monitoring and workflow systems

This makes Baxter an important supplier across several stages of hospital care.

Frequently Asked Questions

Is Baxter an American company?

Yes. Baxter International Inc. is an American healthcare company headquartered in the United States.

What does Baxter manufacture?

Baxter manufactures and supplies products for infusion therapy, IV solutions, clinical nutrition, critical care, surgery, hospital care, respiratory care and pharmaceuticals.

Is Baxter known for infusion pumps?

Yes. Infusion therapy is one of Baxter’s major product areas. Its portfolio includes the IQX Infusion Platform, Spectrum IQ Large Volume Pump and Novum IQ Syringe Pump.

Does Baxter make dialysis machines?

Historically, yes. Baxter’s Kidney Care business included dialysis machines, dialysers, peritoneal-dialysis systems and acute renal-replacement technologies. However, Baxter sold its Kidney Care business in 2025, so these renal products are now associated with the separate Vantive business.

What is Baxter’s PRISMAFLEX system?

PRISMAFLEX is a critical-care extracorporeal therapy system associated with continuous renal replacement and other blood-purification therapies.

Does Baxter make surgical products?

Yes. Baxter offers surgical hemostats, sealants, adhesion-prevention products and other surgical technologies. Examples include FLOSEAL, TISSEEL and COSEAL.

Does Baxter make IV fluids?

Yes. Baxter produces a broad range of IV solutions and related hospital-care products.

Does Baxter make nutrition products?

Yes. Baxter provides clinical and parenteral nutrition products and technologies, including CLINIMIX and automated compounding solutions.

Does Baxter operate in India?

Yes. Baxter has an India operation and a locally listed portfolio covering several healthcare categories.

What happened to Baxter’s Kidney Care business?

Baxter completed the separation/sale of its Kidney Care business in 2025. The renal-care business became Vantive, so current information about dialysis products should distinguish Vantive from Baxter’s remaining businesses.

Conclusion

Baxter International is a major American healthcare company with a long history in infusion therapy, critical care, hospital products, clinical nutrition, surgery and pharmaceuticals.

Its infusion portfolio includes connected pump technologies such as the IQX Infusion Platform, while its hospital portfolio includes IV solutions, nutrition products, surgical hemostats, sealants, patient-monitoring technologies and smart hospital solutions.

Baxter also has a major historical connection with renal care and dialysis. Its former Kidney Care business included haemodialysis, peritoneal dialysis and continuous renal replacement technologies. Following the 2025 separation of that business, renal products should now be distinguished from Baxter’s current core portfolio.

Overall, Baxter remains an important medical-technology company serving hospitals, critical-care units, operating rooms and other healthcare environments around the world.